J. A. Stakkestad

Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis

Charles H. Chesnut, Arne Skag, Claus Christiansen et al. · Journal of Bone and Mineral Research · 2004 · 1.2K citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

Conjugated Linoleic Acid Reduces Body Fat Mass in Overweight and Obese Humans

Ola Gudmundsen, Henrietta Blankson, J. A. Stakkestad et al. · Journal of Nutrition · 2000 · 597 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +12

Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1-Year Results From the MOBILE Study

Paul D. Miller, Michael R. McClung, Liviu Macovei et al. · Journal of Bone and Mineral Research · 2005 · 334 citations

Medicine, Endocrinology, Bone Metabolism +9

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

Pierre D. Delmas, Robert R. Recker, C. H. Chesnut et al. · Osteoporosis International · 2004 · 279 citations

Medicine, Endocrinology, Bone Metabolism +13

Intravenous ibandronate injections in postmenopausal women with osteoporosis: One‐year results from the dosing intravenous administration study

Pierre D. Delmas, Silvano Adami, Cezary Strugała et al. · Arthritis & Rheumatism · 2006 · 258 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16